Literature DB >> 19271167

Evaluation on quality of life and analysis on its correlation with TCM syndromes in patients of chronic hepatitis B.

Wei Zhang1, Li-Qiong Wang, Yi-Bo Liu.   

Abstract

OBJECTIVE: To evaluate the quality of life (QOL) in patients with chronic hepatitis B (CHB) and analyze its correlation with traditional Chinese medicine (TCM) syndrome types.
METHODS: With cross-sectional investigation adopted, the QOL of 335 CHB patients was studied by the World Health Organization Quality of Life BREF Questionnaire (WHOQOL-BREF) and the chronic liver disease questionnaire (CLDQ). The results was compared with that of 30 healthy persons.
RESULTS: The QOL of the patients with chronic hepatitis B was lower than the healthy persons with signififi cant difference between them (P<0.01). Also it was different in patients of different TCM syndrome types (P<0.05 or P<0.01). The lowest QOL was shown in patients of the blood-stasis blocking vessel type and Gan ()-stagnation with Pi ()-defificiency type (P<0.01).
CONCLUSION: The QOL of CHB patients is lower than of healthy persons and closely correlated with TCM syndrome types.

Entities:  

Mesh:

Year:  2009        PMID: 19271167     DOI: 10.1007/s11655-009-0030-z

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  4 in total

1.  A modular approach to quality-of-life assessment in cancer clinical trials.

Authors:  N K Aaronson; M Bullinger; S Ahmedzai
Journal:  Recent Results Cancer Res       Date:  1988

2.  The factorial structure of the Chronic Liver Disease Questionnaire (CLDQ).

Authors:  Karl-Heinz Schulz; Sylvia Kroencke; Heike Ewers; Holger Schulz; Zobair M Younossi
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

3.  Health-related quality of life in patients with chronic hepatitis B.

Authors:  Silvia Bondini; Jillian Kallman; Amy Dan; Zahra Younoszai; Lolita Ramsey; Fatema Nader; Zobair M Younossi
Journal:  Liver Int       Date:  2007-10       Impact factor: 5.828

4.  Who should measure quality of life, the doctor or the patient?

Authors:  M L Slevin; H Plant; D Lynch; J Drinkwater; W M Gregory
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.